Carladenise Armbrister Edwards - 22 Jul 2022 Form 4 Insider Report for CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)

Role
Director
Signature
/s/ Joseph R. Martin, as Attorney-in-Fact
Issuer symbol
CLOV
Transactions as of
22 Jul 2022
Net transactions value
$0
Form type
4
Filing time
26 Jul 2022, 16:26:51 UTC
Next filing
26 Sep 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CLOV Class A Common Stock Award $0 +8,805 $0.000000 8,805 22 Jul 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of Class A common stock of Clover Health Investments, Corp. (the "Company") underlying a time-based restricted stock unit award ("RSUs"). The RSUs will vest in full on September 22, 2022, the date of the Company's 2022 annual meeting of stockholders, subject to the Reporting Person's continued service as a member of the Board through such vesting date.